1. Clayton, D. F., and J. M. George. 1998. The synucleins: A family
of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21: 249–254.
2. Crino, P. B., J. A. Martin, W. D. Hill, B. Greenberg, V. M. Y. Lee,
and J. Q. Trojanowski. 1995. Beta-Amyloid peptide and amyloid
precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome. Ann.
18.
Otol. Rhinol. Laryngol. 104: 655–661.
3. Doty, R. L., P. F. Reyes, and T. Gregor. 1987. Presence of both
odor identification and detection deficits in Alzheimer's disease.
Brain Res. Bull. 18: 597–600.
19.
4. Doty, R. L., M. Riklan, D. A. Deems, C. Reynolds, and S. Stellar.
1989. The olfactory and cognitive deficits of Parkinson's disease:
Evidence for independence. Ann. Neurol. 25: 166–171.
20.
5. George, J. M., H. Jin, W. S. Woods, and D. F. Clayton. 1995.
Characterization of a novel protein regulated during the critical
period for song learning in the zebra finch. Neuron 15: 361–372.
6. Giasson, B., K. Uryu, J. Q. Trojanowski, and V. M. Y. Lee. 1999.
Mutant and wild type human alpha-synucleins assemble into 21.
elongated filaments with distinct morphologies in vitro. J. Biol.
Chem. 274: 7619–7622.
7. Gilman, S., P. A. Low, N. Quinn, A. Albanese, Y. Ben-Shlomo, 22.
C. J. Fowler, H. Kaufmann, T. Klockgether, A. E. Lang, P. L.
Lantos, I. Litvan, C. J. Mathias, E. Oliver, D. Robertson, I.
Schatz, and G. K. Wenning. 1999. Consensus statement on the
